Latest Commercialization News

BCAL Diagnostics has partnered with US-based ClearNote Health to exclusively distribute innovative blood tests for early detection of pancreatic and ovarian cancers in Australia and New Zealand, starting early 2026.

Andromeda Metals' latest Scoping Study reveals a compelling economic case for its innovative High Purity Alumina (HPA) production technology, highlighting strong returns and a significant carbon emissions advantage. The project aims to meet soaring global demand with a 10,000 tonne per annum facility in South Australia.

Blue Star Helium Limited reports steady progress on its Galactica helium project in Colorado, with first helium production on track for December 2025 and full ramp-up expected through 2026.

Blue Star Helium has decided not to exercise its purchase option on key Colorado helium assets after thorough evaluation, signaling a strategic pivot in its growth approach.

Pathkey.AI has upgraded its TrialKey platform to include drug-level molecular and pharmacokinetic features, enhancing clinical trial predictions and opening doors to AI-driven drug discovery.

Renascor Resources has begun construction of its Purified Spherical Graphite demonstration facility in Adelaide, aiming to showcase an innovative HF-free purification process and disrupt China’s near-monopoly on PSG supply.

Lithium Universe Limited reports a major advance in silver recycling technology, achieving near-Britannia-grade purity in just five minutes using its proprietary JESE method. This innovation promises to reshape solar panel recycling with higher efficiency and sustainability.

Imricor Medical Systems has successfully completed a comprehensive Human Factors study for all its devices under FDA review, marking a critical milestone towards U.S. market entry. The extensive 7-month study involved 46 healthcare professionals and tested nine products, underscoring Imricor’s growing momentum in electrophysiology innovation.

Buru Energy has secured environmental approval for its 2026 Rafael resource appraisal drilling campaign, a crucial step toward final investment and first cashflows by 2028.

Proteomics International Laboratories has achieved ISO 15189 certification for its Australian lab, marking a pivotal step in commercialising its precision diagnostic tests like PromarkerD and PromarkerEso.

Meteoric Resources has confirmed exceptional rare earth recoveries from continuous piloting at ANSTO, producing high-quality Mixed Rare Earth Carbonate and demonstrating effective waste handling. This milestone advances the Caldeira Project towards commercial development and offtake agreements.

Robex Resources has moved up the expiry date of its 2024 Warrants to October 2025 after its share price hit a key threshold, potentially unlocking C$147 million to fund its Kiniero Gold Project in Guinea.